Drugs / Broncho-Vaxom (BV)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02148796 Comparator | Jan 2017 → Jan 2026 | asthma | University of Arizona | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Broncho-Vaxom (BV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02148796 ↗ |
| Known as | OM-85 BV | “Active Ingredient: Lyophilised bacterial extract; Chemical Name: OM-85 BV; Strength: 3.5 mg” NCT02148796 ↗ |
| Modality | Other / unclassified | “Active Ingredient: Lyophilised bacterial extract” NCT02148796 ↗ |
| Route | Oral | “Oral Bacterial Extract” NCT02148796 ↗ |